Fergus McTaggart - Concepedia

Author

Fergus McTaggart

AstraZeneca (United Kingdom)

Also Known As

F McTaggart, F. MCTAGGART, F. McTaggart, Fergus McTaggart

Publications

Citations

H-Index

Concepts

All Affiliations

AstraZeneca (United Kingdom)Courtauld Institute of Art AstraZeneca (United States)

About

Fergus McTaggart is an author at AstraZeneca (United Kingdom) specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	1.1K
2	Biochemistry	11	11	891
3	Health Sciences	3	3	172
4	Natural Sciences	3	3	453
5	Cell Biology	1	1	156

Fergus McTaggart

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Preclinical and clinical pharmacology of rosuvastatin, a new 3-hydroxy- 3-methylglutaryl coenzyme A reductase inhibitor11CRESTOR is a trademark, the property of AstraZeneca PLC. Research discussed in this article was supported by AstraZeneca. Fergus McTaggart, Linda K. Buckett, Robert G. Davidson, The American Journal of Cardiology Molecular PharmacologyMedicinal ChemistryPharmaceutical ScienceOxysterolBiochemistry	2001	412
Inhibitors of 3-Hydroxy-3-Methylglutaryl–CoA Reductase Reduce Receptor-Mediated Endocytosis in Opossum Kidney Cells James E. Sidaway, Robert G. Davidson, Fergus McTaggart, Journal of the American Society of Nephrology Albumin UptakeCytoskeletonNephrologyOpossum Kidney CellsCellular Physiology	2004	156
Phenotype-dependent and -independent actions of rosuvastatin on atherogenic lipoprotein subfractions in hyperlipidaemia Muriel Caslake, Grace Stewart, Stephen Day, Atherosclerosis Metabolic SyndromeAtherogenic Lipoprotein Subfractions-Independent ActionsCardiovascular DiseaseBiochemistry	2003	89
Comparison of the Effects of High Doses of Rosuvastatin Versus Atorvastatin on the Subpopulations of High-Density Lipoproteins Bela F. Asztalos, Florence Le Maulf, Gerald E. Dallal, The American Journal of Cardiology ThrombosisCardiovascular DiseaseMedicineHigh-density LipoproteinsHigh Doses	2007	84
Effect of Short-Term Rosuvastatin Treatment on Estimated Glomerular Filtration Rate Donald G. Vidt, Susan S. Harris, Fergus McTaggart, The American Journal of Cardiology HemodialysisUrologyRenal FunctionKidney FailureChronic Kidney Disease	2006	74
Synthesis and Activity of a Novel Series of 3-Biarylquinuclidine Squalene Synthase Inhibitors George R. Brown, David S. Clarke, Alan J. Foubister, Journal of Medicinal Chemistry	1996	66
Selectivity of ZD4522 for inhibition of cholesterol synthesis in hepatic versus non-hepatic cells Linda K. Buckett, Peter Ballard, Robert G. Davidson, Atherosclerosis OxysterolBiochemistryMedicineLiver PhysiologyLipid Peroxidation	2000	57
Some effects of diet on guinea pig serum lipoproteins G.L. Mills, M. John Chapman, Fergus McTaggart Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism NutritionMetabolic SyndromeBody CompositionPhysiologyLipoprotein Metabolism	1972	50
Inhibition of squalene synthase of rat liver by novel 3′ substituted quinuclidines Fergus McTaggart, George R. Brown, Robert G. Davidson, Biochemical Pharmacology BiochemistrySqualene SynthaseOrganic ChemistryNovel 3′Pharmacology	1996	41
Pharmacological properties of ZD4522 — A new HMG-CoA reductase inhibitor Graeme Smith, Robert G. Davidson, Stuart Bloor, Atherosclerosis Redox SignalingMolecular PharmacologyBiochemistryMedicinePharmacological Properties	2000	37

Page 1